Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer
Emory University
Emory University
University of Kansas Medical Center
Mayo Clinic
University of Chicago
EMD Serono
Roswell Park Cancer Institute
Mayo Clinic
University of Southern California
Washington University School of Medicine
Boehringer Ingelheim
University of Chicago